HSBC Holdings’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $209K | Sell |
7,197
-6,292
| -47% | -$182K | ﹤0.01% | 2185 |
|
|
2025
Q1 | $439K | Buy |
13,489
+937
| +7% | +$30.5K | ﹤0.01% | 1720 |
|
|
2024
Q4 | $645K | Buy |
12,552
+4,788
| +62% | +$246K | ﹤0.01% | 1648 |
|
|
2024
Q3 | $398K | Sell |
7,764
-3,184
| -29% | -$163K | ﹤0.01% | 1776 |
|
|
2024
Q2 | $478K | Buy |
10,948
+4,072
| +59% | +$178K | ﹤0.01% | 1652 |
|
|
2024
Q1 | $322K | Buy |
+6,876
| New | +$322K | ﹤0.01% | 2006 |
|
|
2023
Q3 | – | Sell |
-12,327
| Closed | -$225K | – | 2190 |
|
|
2023
Q2 | $225K | Buy |
+12,327
| New | +$225K | ﹤0.01% | 1853 |
|
|
2021
Q1 | – | Sell |
-17,868
| Closed | -$252K | – | 2376 |
|
|
2020
Q4 | $252K | Buy |
17,868
+1,791
| +11% | +$25.3K | ﹤0.01% | 2250 |
|
|
2020
Q3 | $249K | Buy |
16,077
+4,598
| +40% | +$71.2K | ﹤0.01% | 1930 |
|
|
2020
Q2 | $201K | Buy |
+11,479
| New | +$201K | ﹤0.01% | 1981 |
|
|
2019
Q4 | – | Sell |
-12,197
| Closed | -$183K | – | 2472 |
|
|
2019
Q3 | $183K | Buy |
+12,197
| New | +$183K | ﹤0.01% | 2294 |
|